Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: An open-label study

  • K. Krause
  • , K. Weller
  • , R. Stefaniak
  • , H. Wittkowski
  • , S. Altrichter
  • , F. Siebenhaar
  • , T. Zuberbier
  • , Marcus Maurer*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)943-950
Number of pages8
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume67
Issue number7
DOIs
Publication statusPublished - Jul 2012
Externally publishedYes

Fields of science

  • 302 Clinical Medicine

Cite this